Suppr超能文献

无症状非持续性室性心动过速患者的植入式心脏复律除颤器事件:装置植入是否合理?

Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified?

作者信息

Russo Andrea M, Nayak Hemal, Verdino Ralph, Springman Jamie, Gerstenfeld Edward, Hsia Henry, Marchlinski Francis E

机构信息

University of Pennsylvania Health System, Philadelphia, Pennsylvania 19104, USA.

出版信息

Pacing Clin Electrophysiol. 2003 Dec;26(12):2289-95. doi: 10.1111/j.1540-8159.2003.00361.x.

Abstract

Primary prevention trials have demonstrated that patients with coronary disease, reduced left ventricular function, and nonsustained ventricular tachycardia (NSVT) have improved survival with implantable cardioverter defibrillator (ICD) therapy, presumably secondary to effective termination of life-threatening arrhythmias. However, stored intracardiac electrograms were not always available and specific arrhythmias leading to ICD therapy were not always known. We examined the occurrence of ICD events in 51 consecutive patients who match the described patient profile to determine the frequency of appropriate and inappropriate ICD therapy. ICD detections were noted in 18 (35%) patients during a median follow-up period of 13.1 months. Appropriate therapy for sustained ventricular tachycardia (VT)/ventricular fibrillation (VF) occurred in 11 (22%) patients, with appropriate shocks in 8 (16%) patients and appropriate antitachycardia pacing (ATP) in 4 (8%) patients. The time to first appropriate therapy occurred at a mean of 17 +/- 12 months (median 18 months, range 3-36 months). Inappropriate therapy occurred in 5 (10%) patients with inappropriate shocks in 4 patients and inappropriate ATP in 2 patients. Inappropriate therapy was delivered for supraventricular arrhythmias (SVAs) in 4 patients and for T wave oversensing in 1 patient. The reason for shock therapy was unknown in 1 patient (2%) due to ICD malfunction. The mean arrhythmia rate leading to appropriate therapy for VT/VF was 232 +/- 72 beats/min (range 181-400 beats/min), and the mean rate leading to inappropriate therapy for SVT was 168 +/- 10 beats/min (range 160-180 beats/min). Patients with coronary disease and asymptomatic NSVT commonly receive appropriate defibrillator therapy. These results support the need for ICD implantation for primary prevention, with attention to careful programming of the detection rate to prevent inappropriate therapy.

摘要

一级预防试验表明,患有冠心病、左心室功能降低且有非持续性室性心动过速(NSVT)的患者接受植入式心脏复律除颤器(ICD)治疗后生存率有所提高,这可能是由于有效终止了危及生命的心律失常。然而,并非总能获得存储的心内电图,导致ICD治疗的特定心律失常也并非总是已知。我们检查了51例符合上述患者特征的连续患者中ICD事件的发生情况,以确定适当和不适当ICD治疗的频率。在中位随访期13.1个月期间,18例(35%)患者记录到ICD检测。11例(22%)患者出现了针对持续性室性心动过速(VT)/心室颤动(VF)的适当治疗,其中8例(16%)患者接受了适当电击,4例(8%)患者接受了适当抗心动过速起搏(ATP)。首次适当治疗的时间平均为17±12个月(中位数18个月,范围3 - 36个月)。5例(10%)患者出现不适当治疗,其中4例患者接受了不适当电击,2例患者接受了不适当ATP。4例患者因室上性心律失常(SVA)接受了不适当治疗,1例患者因T波感知过度接受了不适当治疗。1例(2%)患者因ICD故障导致电击治疗原因不明。导致VT/VF适当治疗的平均心律失常率为232±72次/分钟(范围181 - 400次/分钟),导致SVT不适当治疗的平均心率为168±10次/分钟(范围160 - 180次/分钟)。患有冠心病和无症状NSVT的患者通常接受适当的除颤器治疗。这些结果支持了一级预防植入ICD的必要性,同时要注意仔细设置检测率以防止不适当治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验